Favre M. Sur une kystique des appareils pilo-sebaces localis ertaines r'ons de la face. Bull Soc Fr Dermatol Syph. 1932. 39:93-6.
Favre M, Racouchot J. [Nodular cutaneous elasteidosis with cysts and comedones.]. Ann Dermatol Syphiligr (Paris). 1951 Nov-Dec. 78(6):681-702. [QxMD MEDLINE Link].
Keough GC, Laws RA, Elston DM. Favre-Racouchot syndrome: a case for smokers' comedones. Arch Dermatol. 1997 Jun. 133(6):796-7. [QxMD MEDLINE Link].
Vogel S, Muhlstadt M, Molin S, Ruzicka T, Schneider J, Herzinger T. Unilateral favre-racouchot disease: evidence for the eiological role of chronic solar damage. Dermatology. 2013. 226:32-4. [QxMD MEDLINE Link].
Pizzati A, Passoni E, Nazzaro G. Monolateral Favre-Racouchot Syndrome Following Long-term Exposure to Infrared Waves. JAMA Dermatol. 2018 May 1. 154 (5):623-625. [QxMD MEDLINE Link].
Breit S, Flaig MJ, Wolff H, Plewig G. Favre-Racouchot-like disease after radiation therapy. J Am Acad Dermatol. 2003 Jul. 49(1):117-9. [QxMD MEDLINE Link].
Friedman SJ, Su WP. Favre-Racouchot syndrome associated with radiation therapy. Cutis. 1983 Mar. 31(3):306-10. [QxMD MEDLINE Link].
Hoff NP, Reifenberger J, Boike E, Homey B, Gerber PA. Radiation-induced Favre-Racouchot disease. Hautarzt. Oct., 2012. 10:766-7. [QxMD MEDLINE Link].
Lim HW, James WD, Rigel DS, Maloney ME, Spencer JM, Bhushan R. Adverse effects of ultraviolet radiation from the use of indoor tanning equipment: time to ban the tan. J Am Acad Dermatol. 2011 May. 64(5):893-902. [QxMD MEDLINE Link].
Patterson WM, Fox MD, Schwartz RA. Favre-Racouchot disease. Int J Dermatol. 2004 Mar. 43(3):167-9. [QxMD MEDLINE Link].
Cardoso F, Nakandakari S, Zattar GA, Soares CT. Actinic comedonal plaque-variant of Favre-Racouchot syndrome: report of two cases. An Bras Dermatol. 2015 Jun. 90 (3 Suppl 1):185-7. [QxMD MEDLINE Link].
Adams BB, Chetty VB, Mutasim DF. Periorbital comedones and their relationship to pitch tar: a cross-sectional analysis and a review of the literature. J Am Acad Dermatol. 2000 Apr. 42(4):624-7. [QxMD MEDLINE Link].
Morgan MB, Stevens GL, Somach S. Multiple follicular cysts, infundibular type with vellus hairs and solar elastosis of the ears: a new dermatoheliosis?. J Cutan Pathol. 2003 Jan. 30(1):29-31. [QxMD MEDLINE Link].
Lewis KG, Bercovitch L, Dill SW, Robinson-Bostom L. Acquired disorders of elastic tissue: part I. Increased elastic tissue and solar elastotic syndromes. J Am Acad Dermatol. 2004 Jul. 51(1):1-21; quiz 22-4. [QxMD MEDLINE Link].
Sanchez-Yus E, del Rio E, Simon P, Requena L, Vazquez H. The histopathology of closed and open comedones of Favre-Racouchot disease. Arch Dermatol. 1997 Jun. 133(6):743-5. [QxMD MEDLINE Link].
Kligman AM, Plewig G, Mills OH Jr. Topically applied tretinoin for senile (solar) comedones. Arch Dermatol. 1971 Oct. 104(4):420-1. [QxMD MEDLINE Link].
Paganelli A, Mandel VD, Kaleci S, Pellacani G, Rossi E. Favre-Racouchot disease: systematic review and possible therapeutic strategies. J Eur Acad Dermatol Venereol. 2019 Jan. 33 (1):32-41. [QxMD MEDLINE Link].
Platsidaki E, Markantoni V, Balamoti E, Kouris A, Rigopoulos D, Kontochristopoulos G. Combination of 30% Salicylic Acid Peels and Mechanical Comedo Extraction for the Treatment of Favre-Racouchot Syndrome. Acta Dermatovenerol Croat. 2019 Mar. 27 (1):42-43. [QxMD MEDLINE Link].
Sharkey MJ, Keller RA, Grabski WJ, McCollough ML. Favre-Racouchot syndrome. A combined therapeutic approach. Arch Dermatol. 1992 May. 128(5):615-6. [QxMD MEDLINE Link].
English DT, Martin GC, Reisner JE. Dermabrasion for nodular cutaneous elastosis with cysts and comedones. Favre-Racouchot syndrome. Arch Dermatol. 1971 Jul. 104(1):92-3. [QxMD MEDLINE Link].
Mohs FE, McCall MW, Greenway HT. Curettage for removal of the comedones and cysts of the Favre-Racouchot syndrome. Arch Dermatol. 1982 May. 118(5):365-6. [QxMD MEDLINE Link].
Mavilia L, Campolmi P, Santoro G, Lotti T. Combined treatment of Favre-Racouchot syndrome with a superpulsed carbon dioxide laser: report of 50 cases. Dermatol Ther. 2010 Jan-Feb. 23 Suppl 1:S4-6. [QxMD MEDLINE Link].
Rai S, Madan V, August PJ, Ferguson JE. Favre Racouchot Syndrome; A novel two- step treatment approach using the carbon dioxide laser. Br J Dermatol. Nov 2013. [Full Text].

Author

Robert P Feinstein, MD, FAAD Associate Clinical Professor, Department of Dermatology, Columbia University Vagelos College of Physicians and Surgeons

Robert P Feinstein, MD, FAAD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Noah Worcester Dermatological Society, Phi Beta Kappa

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Edward F Chan, MD Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine

Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Andrea Leigh Zaenglein, MD Professor of Dermatology and Pediatrics, Department of Dermatology, Hershey Medical Center, Pennsylvania State University College of Medicine

Andrea Leigh Zaenglein, MD is a member of the following medical societies: American Academy of Dermatology, Society for Pediatric Dermatology

Disclosure: Received consulting fee from Galderma for consulting; Received consulting fee from Valeant for consulting; Received consulting fee from Promius for consulting; Received consulting fee from Anacor for consulting; Received grant/research funds from Stiefel for investigator; Received grant/research funds from Astellas for investigator; Received grant/research funds from Ranbaxy for other; Received consulting fee from Ranbaxy for consulting.